Hostname: page-component-848d4c4894-ndmmz Total loading time: 0 Render date: 2024-05-03T12:15:57.889Z Has data issue: false hasContentIssue false

Effects of inhibitors of sclerotium formation on the sclerotial mycoparasite Coniothyrium minitans and its host Sclerotinia sclerotiorum

Published online by Cambridge University Press:  17 January 2001

A. DIAMANTOPOULOU
Affiliation:
Department of Biology, University of Patras, 26500 RON, Greece
J. LITKEI
Affiliation:
Faculty of Agriculture, University of Szarvas, 5540 Szarvas, Hungary
C. SKOPA
Affiliation:
Department of Biology, University of Patras, 26500 RON, Greece
C. CHRISTIAS
Affiliation:
Department of Biology, University of Patras, 26500 RON, Greece
Get access

Abstract

The formation of sclerotia is inhibited by certain chemicals. These resting fungal structures are also parasitized by mycoparasites. This study reports results of experiments on the effect of four sclerotial inhibitors on the sclerotial mycoparasite Coniothyrium minitans and was carried out in an attempt to determine possible compatibilities between sclerotial inhibitors and mycoparasites. Thioglycolic acid was the most toxic to mycelial growth while its sodium salt was totally non-toxic. Mercaptoethanol and mercaptoethylamine were intermediate. At low concentrations, pycnidial formation by C. minitans was not hindered by any of the compounds tested. All four compounds inhibited the formation of sclerotia in Sclerotinia sclerotiorum. Sclerotia are also parasitized by C. minitans. Na-thioglycolate should be tested further as it had no adverse effect on the mycelial growth and pycnidium formation in C. minitans, while it inhibited extensively the formation of sclerotia in S. sclerotiorum. These data suggest that Na-thioglycolate and C. minitans should be considered for use in integrated control.

Type
Research Article
Copyright
© The British Mycological Society 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)